Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN

Sonnet BioTherapeutics Holdings (SONN) Technical Analysis

341 Followers

Summary of all the Indicators

Summary
Neutral
10Bullish
2Neutral
10Bearish
Oscillators
Sell
2Bullish
2Neutral
6Bearish
Moving Averages
Buy
8Bullish
0Neutral
4Bearish
Sonnet BioTherapeutics Holdings’s (SONN) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Sonnet BioTherapeutics Holdings is a Sell.
Sonnet BioTherapeutics Holdings’s (SONN) 20-Day exponential moving average is 0.36, while Sonnet BioTherapeutics Holdings’s (SONN) share price is $0.502, making it a Buy.
Sonnet BioTherapeutics Holdings’s (SONN) 50-Day exponential moving average is 0.40, while Sonnet BioTherapeutics Holdings’s (SONN) share price is $0.502, making it a Buy.

Sonnet BioTherapeutics Holdings (SONN) Pivot Points

Jun 04, 2023, 09:34 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.42
0.45
0.46
0.49
0.51
0.54
0.55
Fibonacci
0.45
0.47
0.48
0.49
0.51
0.52
0.54

Sonnet BioTherapeutics Holdings (SONN) Moving Averages

Jun 04, 2023, 09:34 PM
Period
Simple
Exponential
MA5
0.48Buy
0.47Buy
MA10
0.39Buy
0.41Buy
MA20
0.32Buy
0.36Buy
MA50
0.32Buy
0.40Buy
MA100
0.64Sell
0.66Sell
MA200
1.16Sell
1.37Sell
Sonnet BioTherapeutics Holdings’s (SONN) 10-Day exponential moving average is 0.41, while Sonnet BioTherapeutics Holdings’s (SONN) share price is $0.502, making it a Buy.
Sonnet BioTherapeutics Holdings’s (SONN) 100-Day exponential moving average is 0.66, while Sonnet BioTherapeutics Holdings’s (SONN) share price is $0.502, making it a Sell.
Sonnet BioTherapeutics Holdings’s (SONN) stock price is $0.502 and Sonnet BioTherapeutics Holdings’s (SONN) 50-day simple moving average is 0.32, creating a Buy signal.
Sonnet BioTherapeutics Holdings’s (SONN) stock price is $0.502 and Sonnet BioTherapeutics Holdings’s (SONN) 100-day simple moving average is 0.64, creating a Sell signal.
Sonnet BioTherapeutics Holdings’s (SONN) stock price is $0.502 and Sonnet BioTherapeutics Holdings’s (SONN) 200-day simple moving average is 1.16, creating a Sell signal.

Sonnet BioTherapeutics Holdings (SONN) Technical Indicators

Jun 04, 2023, 09:34 PM
Name
Value
Action
RSI (14)
74.14
Sell
STOCH (9,6)
85.89
Sell
STOCHRSI (14)
87.14
Sell
MACD (12,26)
0.05
Sell
ADX (14)
36.90
Neutral
Williams %R
-11.95
Sell
CCI (14)
122.66
Sell
ATR (14)
0.06
-
Ultimate Oscillator
59.08
Neutral
ROC
127.27
Buy
Sonnet BioTherapeutics Holdings’s (SONN) Relative Strength Index (RSI) is 74.14, creating a Sell signal.
Sonnet BioTherapeutics Holdings’s (SONN) Trend Strength Indicator (ADX) is 36.90, creating a Neutral signal.
Sonnet BioTherapeutics Holdings’s (SONN) Commodity Channel Index (CCI) is 122.66, creating a Sell signal.
Sonnet BioTherapeutics Holdings’s (SONN) Price Rate of Change (ROC) is 127.27, creating a Buy signal.

FAQ

Is SONN a Buy, Hold, or Sell?
Based on SONN’s technical indicators, SONN is a Hold.
    What is SONN’s RSI (14)?
    SONN’s RSI (14) is 74.14, which suggests SONN is a Sell.
      What is SONN’s MACD?
      SONN’s MACD is 0.05, which suggests SONN is a Sell.
        What is SONN’s 5-day moving average?
        SONN’s 5-day moving average is 0.48, which suggests SONN is a Buy.
          What is SONN’s 20-day moving average?
          SONN 20-day moving average is 0.32, which suggests SONN is a Buy.
            What is SONN’s 50-day moving average?
            SONN’s 50-day moving average is 0.32, which suggests SONN is a Buy.
              What is SONN’s 200-day moving average?
              SONN’s 200-day moving average is 1.16, which suggests SONN is a Sell.
                What is SONN’s Williams % R (14)?
                SONN’s Williams % R (14) is -11.95, which suggests SONN is a Sell.
                  What is SONN’s CCI (14)?
                  SONN’s CCI (14) is 122.66, which suggests SONN is a Sell.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis